Lam Research
LRCX
$254.39
+0.22%
Lam Research is one of the world's largest semiconductor wafer fabrication equipment manufacturers, specializing in deposition and etch processes that build up and selectively remove material layers during chip production, serving memory (DRAM/NAND) and logic foundry customers including TSMC, Samsung, Intel, and Micron. The company holds the top market share in etch and a clear second position in deposition, giving it a critical chokepoint role in advanced-node manufacturing rather than a commodity supplier position. The current investor narrative centers on AI-driven semiconductor complexity — record quarterly results and raised long-term targets tied to demand for higher-aspect-ratio etch and advanced packaging — with recent coverage debating whether Lam could eventually become a trillion-dollar company. That bullish structural story is now colliding with a sharp momentum reversal, as the stock has sold off hard from its summer highs despite strong fundamentals, leaving investors to debate whether this is a healthy reset in a secular uptrend or an early warning of a cyclical peak in wafer fab equipment spending.…
LRCX
Lam Research
$254.39
Related headlines
LRCX 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lam Research's 12-month outlook, with a consensus price target around $364.03 and implied upside of +43.1% versus the current price.
Average Target
$364.03
0 analysts
Implied Upside
+43.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$255 - $500
Analyst target range
Coverage is deep and overwhelmingly bullish: 30 analysts cover Lam with a consensus recommendation of "strong_buy" (mean rating 1.41 on a 1-5 scale), and the average target price of $364.03 implies +58.2% upside from the current $230.10. Consensus estimates call for average EPS of $18.67 (range $16.42-$21.19) on average revenue of $60.28 billion, underscoring that the Street expects a substantial earnings recovery. The bullish tilt is reinforced by recent institutional ratings — UBS reiterated Buy on September 1, Mizuho Outperform on August 25, and a cluster of Overweight/Buy reiterations from Wells Fargo, Morgan Stanley, Jefferies, Needham, and B. Riley around July 30 — with no downgrades visible in the provided data.
The target range of $255 to $500 is extremely wide (a $245 spread, or roughly 67% of the current price), signaling high uncertainty about the cycle's magnitude. The $500 high target likely assumes sustained AI-driven order growth, multiple expansion back toward summer highs, and successful execution on raised long-term targets; the $255 low target — still 10.8% above the current price — prices in margin compression, a memory capex pause, or a broader semiconductor downturn. Notably, even the lowest analyst target sits above the current price, suggesting the selloff has overshot fundamental expectations, but the wide dispersion and the stock's 1.854 beta mean investors should expect continued volatility and treat the consensus as a directional signal rather than a precise price forecast.
Drowning in data?
Find the real signal!
Bulls vs Bears: LRCX Investment Factors
The evidence is genuinely split: the fundamental case (30% YoY revenue growth, 51.75% gross margins, 58% ROE, strong_buy consensus with 58% upside) is objectively stronger than the technical case, but the market is voting otherwise with a 25% one-month decline and a capitulation-style -11.8% single day. The bear side currently has momentum and valuation on its side — 22x sales and 41x book are near multi-year highs and are compressing — while the bull side has earnings trajectory and analyst conviction. The single most important tension is whether the AI-driven wafer fab equipment upcycle has years to run (justifying the forward EPS step-up to $18.67) or whether the July peak near $438 marked a cyclical top in WFE spending. How that resolves — visible in the next one to two earnings reports and memory capex commentary from Samsung and Micron — will determine whether $230 is a generational entry or a value trap.
Bullish
- Revenue ramp accelerating quarter over quarter: Fiscal Q4 2026 revenue hit $6.722 billion, up 29.99% year-over-year and roughly 26% sequentially from $5.324 billion in Q1. The system segment drove $4.250 billion of that, showing new tool shipments — not just the installed-base annuity — are powering the surge.
- Elite margins with pricing power: Gross margin expanded to 51.75% in Q4 from 49.83% in Q3 and 49.60% in Q2, while operating margin reached 37.39% and net margin 33.88%. For a capital-intensive equipment maker, sustaining >50% gross margins in etch and deposition reflects genuine pricing power at its chokepoint share position.
- Analyst consensus overwhelmingly bullish: 30 analysts carry a strong_buy consensus (mean rating 1.41) with an average target of $364.03, implying +58.2% upside from $230.10. Notably, even the lowest target of $255 sits 10.8% above the current price, suggesting the selloff has overshot fundamental expectations.
- Fortress balance sheet and returns: Debt-to-equity is just 0.330, the current ratio is 2.63, and cash stands at $5.598 billion against trailing FCF of $4.891 billion. ROE of 58.26% and ROA of 25.01% are top-tier, and the company still returned $325.3 million in dividends plus $246.6 million in buybacks in Q4.
Bearish
- Violent momentum breakdown: The stock is down 25.12% in one month and 24.61% in three months, including an -11.8% single-day drop from $260.81 to $230.15 on 12.19 million shares. It now sits 47.5% below its $438.50 high and just 52.5% through its 52-week range, with a 46.9% max drawdown.
- Extreme valuation multiples: PS is 22.20x, EV/EBITDA 59.08x, and price-to-book 41.35x — versus PB of 12.58x in mid-2025 and 9.81x in early 2025. These multiples capitalize peak-cycle margins and leave little room for any deceleration.
- Trailing PE of 70.97x demands perfection: The trailing PE of 70.97x versus forward PE of 18.99x implies the market expects earnings to roughly quadruple to the $18.67 consensus EPS. Any shortfall in that step-up would trigger sharp multiple compression, which the recent 25% decline may already be signaling.
- FCF conversion deteriorating: Q4 operating cash flow of $1.457 billion minus $634.8 million capex yielded only $822.4 million of FCF, well below Q2's $1.665 billion, driven by a $1.039 billion working-capital drain. If receivables and inventory keep building with the revenue ramp, cash generation lags reported earnings.
LRCX Technical Analysis
Lam Research is in a violent correction within a still-positive longer-term uptrend: the stock is up 55.96% over the past year and 24.34% year-to-date, but at $230.10 it sits just 52.5% of the way through its 52-week range of $135.50 to $438.50 — roughly 47.5% below the high and 69.8% above the low. That positioning means the stock has surrendered the majority of its 2026 gains from the peak and is now testing the lower half of its annual range, a zone that historically separates a deep pullback from a full trend breakdown. The 46.9% max drawdown underscores how severe the de-rating has been for a mega-cap equipment leader.
Short-term momentum is decisively negative and decelerating sharply: the stock is down 25.12% over the past month and 24.61% over three months, versus a 1-year gain of 55.96%, a clear divergence signaling that the intermediate trend has rolled over even as the annual trend remains positive. Relative strength confirms the underperformance — -24.10% versus SPY over one month and -27.46% over three months, against +42.83% over one year — meaning the stock is being sold far harder than the market during this stretch. The most recent sessions are the most alarming: a drop from $260.81 on October 21 to $230.15 on October 22 (-11.8% in a single day) on volume of 12.19 million shares, followed by a flat $230.10 close, suggesting capitulation-style selling rather than orderly profit-taking.
Key technical levels are now well defined: support sits at the $230 area just tested, with the next major floor at the 52-week low of $135.50, while resistance is layered at $260-$270 (the broken October shelf) and then the $438.50 52-week high. A breakdown below $230 would open the door toward the $200 psychological level and potentially the low-$200s, whereas reclaiming $260 would be the first sign of stabilization. With a beta of 1.854, Lam is roughly 85% more volatile than the S&P 500, so position sizing must account for amplified drawdowns — the current 46.9% peak-to-trough decline is a textbook example of how high-beta semis equipment names behave in risk-off rotations.
Beta
1.85
1.85x market volatility
Max Drawdown
-46.9%
Largest decline past year
52-Week Range
$136-$439
Price range past year
Annual Return
+58.3%
Cumulative gain past year
| Period | LRCX Return | S&P 500 |
|---|---|---|
| 1m | -21.5% | +0.7% |
| 3m | -13.2% | +3.0% |
| 6m | -0.9% | +6.8% |
| 1y | +58.3% | +11.9% |
| ytd | +37.5% | +12.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LRCX Fundamental Analysis
Revenue is accelerating powerfully: fiscal Q4 2026 (quarter ended June 28, 2026) revenue reached $6.722 billion, up 29.99% year-over-year, and up sequentially from $5.841 billion in Q3, $5.345 billion in Q2, and $5.324 billion in Q1 — a clear multi-quarter ramp. The system segment contributed $4.250 billion versus $2.472 billion from customer support and other, showing that new tool shipments, not just the installed-base annuity, are driving the surge. This trajectory — roughly 26% sequential growth from Q1 to Q4 — implies AI-related capacity buildout is translating directly into equipment orders, which supports the bull case that the current cycle has legs beyond a single quarter.
Profitability is exceptional and expanding: Q4 net income was $2.278 billion on a 33.88% net margin, with gross margin at 51.75% (up from 49.83% in Q3 and 49.60% in Q2) and operating margin at 37.39%. EPS diluted rose to $1.81 from $1.45 in Q3 and $1.26 in Q2, a steady upward march, while R&D spending of $642.9 million (9.6% of revenue) shows the company is funding innovation without sacrificing margins. For a capital-intensive equipment maker, gross margins above 50% and net margins above 30% are top-tier and reflect pricing power in etch and deposition, where Lam's share position is strongest.
Balance sheet and cash flow are solid but show some working-capital strain: debt-to-equity is just 0.330, the current ratio is 2.63, and cash stood at $5.598 billion at quarter-end, while trailing free cash flow was $4.891 billion. However, Q4 operating cash flow of $1.457 billion minus capex of $634.8 million yielded only $822.4 million of FCF, well below the $1.665 billion generated in Q2, largely due to a $1.039 billion working-capital drain. ROE of 58.26% and ROA of 25.01% are outstanding, and the company returned cash via $325.3 million in dividends and $246.6 million in buybacks in Q4, but the FCF conversion dip bears watching if receivables and inventory continue to build with the revenue ramp.
Quarterly Revenue
$6.7B
2026-06
Revenue YoY Growth
+30.0%
YoY Comparison
Gross Margin
51.7%
Latest Quarter
Free Cash Flow
$4.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LRCX Overvalued?
Because Lam is solidly profitable (Q4 net income of $2.278 billion), the PE ratio is the appropriate primary metric: the trailing PE is 70.97x while the forward PE is 18.99x, an enormous gap that implies the market expects earnings to roughly quadruple. That gap is partly an artifact of a depressed trailing EPS base (the reported $0.014 metric appears distorted), but even using the quarterly run-rate EPS of $1.81 annualized (~$7.24), the forward multiple of ~19x on consensus FY EPS of $18.67 suggests analysts expect a massive earnings step-up. The market is clearly pricing in a strong cyclical upcycle rather than steady-state earnings.
On other multiples the stock looks expensive: PS is 22.20x, EV/Sales 10.86x, EV/EBITDA 59.08x, and price-to-book 41.35x, with a PEG of 1.83. No explicit industry-average multiples were provided in the valuation data, so a precise peer spread cannot be quantified; however, a 22x sales multiple and 59x EV/EBITDA are well above what is typical for semiconductor equipment peers and imply the market is capitalizing peak-cycle margins. The premium is defensible only if the AI-driven revenue ramp (29.99% YoY growth) and 50%+ gross margins persist — any deceleration would compress these multiples quickly.
Historical context is striking: Lam's own PE ratio was 18.03x at the June 2025 quarter-end and 34.23x at the March 2026 quarter-end, versus 70.97x trailing today, while PS has climbed from 23.99x (June 2025) to 76.72x in the latest historical-ratio snapshot — near the top of its multi-year band. PB of 41.35x compares with 12.58x in mid-2025 and 9.81x in early 2025, an extreme expansion. This suggests the market has been pricing highly optimistic expectations, and the recent 25% one-month decline is consistent with multiple compression beginning as investors question whether peak optimism is already reflected.
PE
71.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
59.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on earnings quality and cyclical dependence. The trailing PE of 70.97x versus forward PE of 18.99x means the entire valuation rests on consensus EPS of $18.67 materializing — roughly 2.6x the annualized Q4 run-rate of ~$7.24 — so any order pushout would be devastating to the multiple. Q4 free cash flow of just $822.4 million against $2.278 billion of net income (a $1.039 billion working-capital drain) shows cash conversion is already straining as receivables and inventory build with the ramp. Revenue is also concentrated in memory (DRAM/NAND) customers like Samsung and Micron, making Lam more cyclical than logic-exposed peers; a memory capex pause would hit the system segment's $4.250 billion quarterly run-rate directly.
Market and competitive risks are dominated by valuation compression and high beta. At 22.20x sales, 59.08x EV/EBITDA, and 41.35x book — versus PB of 12.58x in mid-2025 — the stock is priced for sustained peak-cycle margins, and the recent 25% one-month decline is consistent with multiple compression beginning. Beta of 1.854 means a broad risk-off rotation in semis hits Lam roughly 85% harder than the index, evidenced by -27.46% relative strength versus SPY over three months. Competitive threats include Applied Materials and Tokyo Electron pushing into etch/deposition share, and the July 2026 'sell the news' reaction to Samsung's strong earnings shows how quickly good news can be priced in and reversed in AI-linked semis.
Worst-case scenario: memory customers (Samsung, Micron) announce capex cuts, Q1 FY2027 guidance misses the $18.67 EPS trajectory, and analysts downgrade from strong_buy, triggering a de-rating toward the $255 low target and then the 52-week low of $135.50. From $230.10, a move to the $255 low target is actually upside, but a full cyclical reset to the $135.50 low would represent a -41.1% loss, and the stock has already demonstrated a 46.9% max drawdown from its $438.50 peak. A realistic adverse case is a retest of the $200 psychological level (-13%) with tail risk to the low-$200s or, in a true WFE downturn, the $135-$160 zone.